₹ 21.5893
NAV
1.6%
Change
₹ 21.5893
NAV (Mar 19)
Last 1Y | 12.2% |
Last 3Y | 16.4% |
Last 5Y | - |
Last 10Y | - |
Since Inception | 11.1% |
6 Month CAGR | -8.5% |
The scheme seeks to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors.
Expense Ratio | 0.21% |
Launched (3Y ago) | 2021-07-02 |
AUM in Crores | 809.2 |
ISIN | INF204KC1089 |
Lock-in | No Lock-in |
Benchmark | NIFTY Pharma Total Return Index |
SIP Minimum | 1000 |
Lumpsum Min. | 5000 |
Fund Name | Till Date CAGR | |
---|---|---|
7.2% | 7.1% | |
6.4% | 6.9% | |
7.5% | 8.7% | |
7.9% | 9% | |
18.7% | 16% |
Fund Name | Till Date CAGR | |
---|---|---|
18.4% | 7.8% | |
18.1% | 10.7% | |
6.7% | 7.5% | |
6.7% | 5.9% | |
5.9% | 5.5% |
Sun Pharmaceutical Industries Ltd. | 24.6 % |
Dr. Reddy's Laboratories Ltd. | 10.9 % |
Cipla Ltd. | 10.8 % |
Divi's Laboratories Ltd. | 8.3 % |
Lupin Ltd. | 6.1 % |
Aurobindo Pharma Ltd. | 5.4 % |
Zydus Lifesciences Ltd. | 4.2 % |
Torrent Pharmaceuticals Ltd. | 3.9 % |
Alkem Laboratories Ltd. | 3.5 % |
Glenmark Pharmaceuticals Ltd. | 2.9 % |
Nippon India Nifty Pharma ETF (G) is an Exchange Traded Fund which is benchmarked to . Nippon India Nifty Pharma ETF (G) is managed by the Nippon India Mutual Fund with the fund managers being Himanshu Mange, Jitendra Tolani. The Nippon India Nifty Pharma ETF (G) was launched on 2021-07-02 with no lock-in period. Since its inception, the fund has delivered 11.086% as a return on investment.The fund has delivered a 1-year return of 12.247%, a 3-year return of 16.386%.
As on 19 Mar, 2025 the NAV of the fund is Rs 21.59 and the AUM is Rs 809.18 crores. The fund charges an expense ratio of 0.21% on an annual basis. You can start a SIP with an investment of a minimum of Rs 100. You can make a lumpsum investment of minimum of Rs 5000.
Since the scheme is benchmarked to , the fund is subject to very high risk and it may witness volatility in the short term. Hence, an exchange-traded fund is more suitable for an investment horizon of more than 5 years. The Nippon India Nifty Pharma ETF (G) has an asset allocation of 0% in equity and equity equivalents and 0% in debt securities.
Scripbox provides a unique feature through which you can compare the performance of Nippon India Nifty Pharma ETF (G) with another fund in a similar category. This way you can make a well-informed investment decision.